EudraGMP Homepage      
 
 
MIA | GMP | API REG | WDA | GDP | Sites Help
Thu 2 Apr 2026 13:05:26 BST
GMP Compliance Menu 
Search
GMP Certificates
Non-Compliance Report


Print Preview
                  
Print Preview (Short version)
                  
Back To Search

 

Landesamt Fuer Arbeitsschutz Soziales Und Gesundheit Schleswig-Holstein

CERTIFICATE NUMBER: DE_SH_01_GMP_2025_0044

CERTIFICATE OF GMP COMPLIANCE OF A MANUFACTURER(1) , (2)

Part 1

Issued following an inspection in accordance with
Art. 111(5) of Directive 2001/83/EC as amended

The competent authority of Germany confirms the following:

The manufacturer: Medac Gesellschaft fuer klinische Spezialpraeparate mbH

Site address: Theaterstr. 6, Wedel, 22880, Germany

OMS Organisation Id. / OMS Location Id.: ORG-100000774 / LOC-100008802


Has been inspected under the national inspection programme in connection with manufacturing authorisation no.  DE_SH_01_MIA_2025_0014  in accordance with Art. 40 of Directive 2001/83/EC, transposed in the following national legislation:Sect. 13 para 1 German Medicinal Product Act (manufacture) and § 72 German Medicinal Product Act (import).


From the knowledge gained during inspection of this manufacturer, the latest of which was conducted on  2025-05-15 , it is considered that it complies with:

  • The principles and guidelines of Good Manufacturing Practice laid down in Directive (EU) 2017/1572. (3)

  • This certificate reflects the status of the manufacturing site at the time of the inspection noted above and should not be relied upon to reflect the compliance status if more than three years have elapsed since the date of that inspection. However, this period of validity may be reduced or extended using regulatory risk management principles by an entry in the Restrictions or Clarifying remarks field. Updates to restrictions or clarifying remarks can be identified through the EudraGMDP website (https://eudragmdp.ema.europa.eu/). This certificate is valid only when presented with all pages and both Parts 1 and 2.

     The authenticity of this certificate may be verified in EudraGMDP. If it does not appear, please contact the issuing authority.

    __________________________________________________________________________________________________________________________
    (1) The certificate referred to in paragraph Art. 111(5) of Directive 2001/83/ECis also applicable to importers.
    (2) Guidance on the interpretation of this template can be found in the Interpretation of the Union format for GMP certificate.
    (3) These requirements fulfil the GMP recommendations of WHO.

    Part 2

    Human Medicinal Products

    1  MANUFACTURING OPERATIONS
    1.1  Sterile products
       1.1.3  Batch certification
    1.2  Non-sterile products
       1.2.2  Batch certification
    1.3  Biological medicinal products (list of product types)
       1.3.2  Batch Certification (list of product types)
               1.3.2.2  Immunological products
               1.3.2.5  Biotechnology products
               1.3.2.6  Human or animal extracted products
    1.5  Packaging
       1.5.2  Secondary packaging

    2  IMPORTATION OF MEDICINAL PRODUCTS
    2.2  Batch certification of imported medicinal products
       2.2.1  Sterile products
               2.2.1.1  Aseptically prepared
               2.2.1.2  Terminally sterilised
       2.2.2  Non-sterile products
       2.2.3  Biological medicinal products
               2.2.3.5  Biotechnology products

    Clarifying remarks (for public users):
    Any restrictions or clarifying remarks related to the scope of these Manufacturing operations To 1.5.2 Also labeling of primary packages of sterile and non-sterile medicinal products Any restrictions or clarifying remarks related to the scope of these Importation operations To 2.2.1 Sterile products: Aseptically prepared - Lyophilisates - Small volume liquids - Other aseptically prepared products: dry substance To 2.2.2 Non-sterile products: - soft gelatine capsules To 2.2.3.5 Biotechnology products: - Lyophilisate

     

     



     
     
     
         
     
     
     
     
    The EudraGMDP database is maintained and operated by the EMA. Access to the general public is granted in order to enhance availability of information related to the EMA mandate. The content of the database is provided by the National Competent Authorities (NCA) of the EEA. For this reason, the EMA accepts no responsibility or liability whatsoever (including but not limited to any direct or consequential loss or damage it might occur to you and/or any other third party) arising out of or in connection with the information on this database. Any questions about the content should be addressed to the relevant NCA. Please click here to get list of NCA's.

    For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI.

    Documents issued by UK authorities up to and including 31 December 2020 remain available for consultation in EudraGMDP. However, they are no longer included or updated from 1 January 2021, with the exception of the documents pertaining to sites located in Northern Ireland.

    [EMA © 2014. EudraGMDP 6.5.4.8 build 2026/01/16 09:45]